Jim Simons's position in Ventyx Biosciences is currently worth $2.1 Million. That's 0.00% of their equity portfolio (1869th largest holding). The investor owns 1.41% of the outstanding Ventyx Biosciences stock. The first Ventyx Biosciences trade was made in Q3 2022. Since then Jim Simons bought shares six more times and sold shares on two occasions. The investor's estimated purchase price is $2.1 Million, resulting in a loss of 0.3%.